OR WAIT null SECS
Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.
This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.
Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.
June 30, 2014
Biotage has launched a purification technology, Accelerated Chromatographic Isolation (ACI), which converts simple flash purification into a faster and more economical way to isolate pure compounds.
June 26, 2014
Jones Packaging introduces a new solid dose vial line in its Toronto facility.
June 18, 2014
New advanced aseptic manufacturing technologies are available for filling liquid pharmaceuticals, including biologics.
June 17, 2014
Funding boosts life-sciences manufacturing in West Michigan.
June 16, 2014
Novartis facility becomes the first US site licensed by the FDA to produce cell-culture influenza vaccines.
June 12, 2014
A new report from GlobalData states that biosimilars will overtake the market share after 2019.
May 27, 2014
GSK reports 5-year vaccine price freeze for countries graduating from GAVI Alliance.
May 21, 2014
Progress in equipment availability, process analytical technology, and advanced process control aids ongoing development of continuous solid-dosage manufacturing processes.
May 15, 2014
New manufacturing capacity at the Le Mans, France facility is being used to scale up antibody drug conjugates.
What challenges do biopharmaceutical manufacturers face when deciding to move from a fed batch process to a continuous process?